Chia-Li Yu

587 total citations
11 papers, 334 citations indexed

About

Chia-Li Yu is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Chia-Li Yu has authored 11 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in Chia-Li Yu's work include T-cell and B-cell Immunology (4 papers), Blood groups and transfusion (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Chia-Li Yu is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Blood groups and transfusion (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Chia-Li Yu collaborates with scholars based in Taiwan, United States and India. Chia-Li Yu's co-authors include Kuang‐Hui Sun, Pan‐Chyr Yang, Yuh‐Pyng Sher, Konan Peck, Cheng‐Wen Wu, Chang‐Youh Tsai, Steve R. Roffler, Jin‐Yuan Shih, Yi-Wen Chu and Shye-Jye Tang and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Chia-Li Yu

10 papers receiving 323 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chia-Li Yu 111 107 98 63 51 11 334
Katrin Friedbichler 187 1.7× 114 1.1× 158 1.6× 65 1.0× 39 0.8× 13 412
Hideki Makino 96 0.9× 67 0.6× 74 0.8× 36 0.6× 170 3.3× 33 419
Min Feng 129 1.2× 165 1.5× 53 0.5× 72 1.1× 79 1.5× 38 496
Kimberly F. Kerstann 174 1.6× 41 0.4× 137 1.4× 67 1.1× 49 1.0× 9 400
S. Muthuramalingam 85 0.8× 137 1.3× 190 1.9× 59 0.9× 44 0.9× 10 346
Yoshitsugu Miki 156 1.4× 146 1.4× 234 2.4× 77 1.2× 82 1.6× 8 487
Keiichi Iwanami 85 0.8× 248 2.3× 100 1.0× 30 0.5× 18 0.4× 25 423
J.P. Farcet 76 0.7× 118 1.1× 77 0.8× 31 0.5× 31 0.6× 10 399
Xiangyang Huang 117 1.1× 78 0.7× 41 0.4× 37 0.6× 86 1.7× 30 386
F. Moritz 289 2.6× 136 1.3× 87 0.9× 61 1.0× 39 0.8× 16 519

Countries citing papers authored by Chia-Li Yu

Since Specialization
Citations

This map shows the geographic impact of Chia-Li Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia-Li Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia-Li Yu more than expected).

Fields of papers citing papers by Chia-Li Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia-Li Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia-Li Yu. The network helps show where Chia-Li Yu may publish in the future.

Co-authorship network of co-authors of Chia-Li Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chia-Li Yu. A scholar is included among the top collaborators of Chia-Li Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia-Li Yu. Chia-Li Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Yu, Chia-Li, et al.. (2026). Interstitial lung disease in systemic sclerosis—a retrospective cross-sectional study in Taiwan. Clinical Rheumatology. 45(2). 1011–1022.
2.
Chang, Yuh-Lih, Jiin‐Cherng Yen, Hsien‐Tzung Liao, et al.. (2020). Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis. Experimental Hematology and Oncology. 9(1). 6–6. 5 indexed citations
5.
Sher, Yuh‐Pyng, Ruey‐Hwang Chou, Wun‐Shaing Wayne Chang, et al.. (2006). Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non–Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness. Cancer Research. 66(24). 11763–11770. 56 indexed citations
6.
Sun, Kuang‐Hui, et al.. (2005). Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-α and iNOS in activated RAW macrophage cell line. Journal of Autoimmunity. 24(2). 135–143. 21 indexed citations
7.
Sher, Yuh‐Pyng, Jin‐Yuan Shih, Pan‐Chyr Yang, et al.. (2005). Prognosis of Non–Small Cell Lung Cancer Patients by Detecting Circulating Cancer Cells in the Peripheral Blood with Multiple Marker Genes. Clinical Cancer Research. 11(1). 173–179. 89 indexed citations
8.
Yu, Chia-Li, Chang‐Youh Tsai, Kuang‐Hui Sun, et al.. (1997). Tamm-Horsfall glycoprotein (THG) is a binder for surface membrane proteins on blood cells and glomerular mesangial cells. Immunopharmacology. 35(3). 237–245. 6 indexed citations
9.
Tsai, Chang‐Youh, Shih-Tzu Tsai, Kuang‐Hui Sun, et al.. (1997). The Expression of Genes Modulating Programmed Cell Death in Normal Human Polymorphonuclear Neutrophils. Biochemical and Biophysical Research Communications. 233(3). 700–706. 57 indexed citations
10.
Yu, Chia-Li, Kuang‐Hui Sun, Chang‐Youh Tsai, et al.. (1994). Interleukin 8 modulates interleukin-1β, interleukin-6 and tumor necrosis factor-α release from normal human mononuclear cells. Immunopharmacology. 27(3). 207–214. 19 indexed citations
11.
Yu, Chia-Li, et al.. (1993). Tamm-Horsfall urinary glycoprotein enhances monokine release and augments lymphocyte proliferation. Immunopharmacology. 26(3). 249–258. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026